Otsuka’s drug eases symptom burden, anxiety in ADHD as FDA verdict nears

By /

The positive ADHD data for Otsuka Pharmaceutical’s centanafadine is good news in what has of late been a mixed bag for the neuropsychiatric space.

Scroll to Top